About Upadoz 30mg
What is Upadoz 30mg?
Upadoz 30mg is an Indian brand of upadacitinib, a Janus kinase (JAK) inhibitor in extended release tablets. Each tablet contains upadacitinib 30 mg. It is made in India by MSN Laboratories.
What it is used for
According to the US FDA label for Rinvoq (DailyMed), upadacitinib is used for moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non radiographic axial spondyloarthritis, ulcerative colitis and Crohn's disease in adults after a TNF blocker did not work or was not tolerated, giant cell arteritis in adults, refractory atopic dermatitis from 12 years, and polyarticular juvenile idiopathic arthritis and psoriatic arthritis from 2 years. On the US label, the 30 mg strength is used for atopic dermatitis and as a maintenance strength for ulcerative colitis and Crohn's disease; the other conditions listed use 15 mg. The US label carries a boxed warning about serious infections including tuberculosis, a higher death rate, cancer, major heart events and blood clots. Your doctor decides whether it suits you.
Packs and price
Upadoz 30mg comes in packs of 30, 60 and 90 tablets. The lowest price works out at about $3.67 per tablet on the 90 tablet pack, as of October 2026; the pack selector shows the current price. Shipping is $25 on orders under $149 and free from $149.
Prescription status
Upadacitinib is a prescription medicine in the US, UK, Australia and Canada. Upadoz 30mg itself is an India made pack and is not approved by the FDA, MHRA, TGA or Health Canada. The FDA says that importing unapproved medicines for personal use is illegal in most circumstances, so check the rules where you live.
Before you order
Read the patient leaflet that comes with the pack. Tell your doctor or pharmacist about any other medicines you take and any health conditions you have. Get urgent medical help if you notice signs of an allergic reaction, such as swelling of the face, lips, tongue or throat, trouble breathing, or a widespread rash.
Delivery
Orders usually arrive in 7 to 14 business days in plain packaging, with a tracking number.
Key Information
- ✓Active Ingredient: Upadacitinib
- ✓Category: Pain
- ✓Form: Tablet
- ✓Brand: Upadoz
- ✓Manufacturer: MSN Laboratories
Frequently Asked Questions
What is Upadoz 30mg?
Upadoz 30mg is an Indian brand of upadacitinib 30 mg, a Janus kinase (JAK) inhibitor in extended release tablets, made by MSN Laboratories.
What is Upadoz 30mg used for?
The US FDA label for Rinvoq (DailyMed) lists moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non radiographic axial spondyloarthritis, ulcerative colitis and Crohn's disease in adults after a TNF blocker did not work or was not tolerated, giant cell arteritis in adults, refractory atopic dermatitis from 12 years, and polyarticular juvenile idiopathic arthritis and psoriatic arthritis from 2 years. On the US label, the 30 mg strength is used for atopic dermatitis and as a maintenance strength for ulcerative colitis and Crohn's disease; the other conditions listed use 15 mg. Your doctor decides whether it is right for you.
Do I need a prescription for upadacitinib?
Upadacitinib is a prescription medicine in the US, UK, Australia and Canada. This India made pack is not approved by the FDA, MHRA, TGA or Health Canada.
How long does delivery of Upadoz 30mg take?
Orders usually arrive in 7 to 14 business days in plain packaging, with tracking.
Related Products
View all
Customer Reviews
No reviews yet. Be the first to review Upadoz 30mg.
Related Articles
Health guides about Upadacitinib, written by pharmacists
Muscle Relaxers Compared: Cyclobenzaprine, Tizanidine, Baclofen and Carisoprodol
Cyclobenzaprine and carisoprodol treat short lived muscle spasm. Baclofen and tizanidine treat spasticity. This comparison puts all four side by side using placebo controlled sedation rates, dosing ceilings, interaction risk and what the long term evidence supports.
Cyclobenzaprine Dosage: 5 mg vs 10 mg and the Three Week Limit
Cyclobenzaprine is dosed at 5 mg three times daily, raised to 10 mg if needed, for two to three weeks at most. Trial data shows drowsiness rising from 19 to 28 points over placebo when the dose doubles, which is the case for starting low.
Tizanidine Dosage and the Drug Interactions That Change It
Tizanidine starts at 2 mg every six to eight hours and tops out at 36 mg daily, but interactions usually decide the ceiling. Ciprofloxacin raises exposure tenfold and fluvoxamine thirty three fold, and both combinations are contraindicated.
Related Health Guide
Understanding Chronic Pain Management: Complete Guide